Moreover, lower SVR rates with DAAs/INF combinations remain associated with some viral and host factors including high HCV viral loads, black race, IL28B CT/TT genotypes, advanced liver fibrosis, and prior HCV treatment experience [2, 3]. This evidence concerns the gene IFNL3 and Hepatic fibrosis.